2Cho CH. New mechanism for glutamate hypothesis in epilep- sy [J]. Front Cell Neurosei, 2013, 7: 127.
3Moch6 SL, Perucca E, Ryvlin P, et al. Epilepsy: new ad- vances [J]. Lancet, 2015, 385(9971) :884-898.
4Nixon JP, Mavanji V, Butterick TA, et al. Sleep disorders, obesity, and aging: the role of orexin ]-J. Ageing Res Rev, 2015,20: 63-73.
5Wilner A, Sharma B, Thompson A, et al. Diagnoses, proce dures, drug utilization, comorbidities, and cost of health care for people with epilepsy in 2012 [J]. Epilepsy Behav, 2014, 41 : 83-90.
6Vlooswijk M, Vaessen M, Jansen J, et al. Loss of network efficiency associated with cognitive decline in chronic epilepsy [J]. Neurology, 2011, 77(10) : 938-944.
7Farina E, Raglio A, Giovagnoli AR. Cognitive rehabilitation in epilepsy: An evidence-based review [J]. Epilepsy Res, 2015, 109:210 218.
8Ahmad M, Abu-Taweel GM, Aboshaiqah AE, et al. The Effects of Quinacrine, Proglumide, and Pentoxifylline on Sei zure Activity, Cognitive Deficit, and Oxidative Stress in Rat Lithium-Pilocarpine Model of Status Epilepticus [J]. Oxid Med Cellular Longev, 2014, 2014:630509.
9Wang W, Wu Y, Zhang G, et al. Activation of Nrf2 ARE signal pathway protects the brain from damage induced by ep ileptic seizure [J]. Brain Res, 2014, 1544:54-61.
10Thompson MD, Xhaard H, Sakurai T, et al. OXI and OX2 orexin/hypocretin receptor pharrnacogenetics [J]. Front Neurosci, 2014, 8:57.
